FILLA, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 4.767
EU - Europa 2.535
AS - Asia 991
AF - Africa 61
SA - Sud America 15
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 8.375
Nazione #
US - Stati Uniti d'America 4.631
CN - Cina 780
IT - Italia 706
NL - Olanda 425
FI - Finlandia 331
UA - Ucraina 298
DE - Germania 244
IE - Irlanda 212
CA - Canada 129
SE - Svezia 105
GB - Regno Unito 85
IN - India 70
VN - Vietnam 60
CI - Costa d'Avorio 46
ES - Italia 32
FR - Francia 30
IL - Israele 16
JP - Giappone 16
BE - Belgio 15
IR - Iran 12
BR - Brasile 11
TR - Turchia 11
AT - Austria 8
ZA - Sudafrica 8
PT - Portogallo 7
RO - Romania 7
SG - Singapore 7
HK - Hong Kong 6
TH - Thailandia 6
BG - Bulgaria 5
MU - Mauritius 5
CH - Svizzera 4
GR - Grecia 4
CU - Cuba 3
EU - Europa 3
PL - Polonia 3
RU - Federazione Russa 3
AU - Australia 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
HU - Ungheria 2
KR - Corea 2
LT - Lituania 2
MX - Messico 2
NO - Norvegia 2
PH - Filippine 2
AL - Albania 1
AR - Argentina 1
AZ - Azerbaigian 1
BZ - Belize 1
CL - Cile 1
CO - Colombia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ID - Indonesia 1
LK - Sri Lanka 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PE - Perù 1
Totale 8.375
Città #
Chandler 999
Millbury 411
Amsterdam 398
Ashburn 356
Princeton 342
Jacksonville 316
Nanjing 251
Boston 162
Naples 162
Beijing 144
Wilmington 140
Ottawa 111
Nanchang 93
Napoli 86
Des Moines 60
Dong Ket 60
Norwalk 57
Woodbridge 47
Jiaxing 46
Shenyang 46
Hebei 45
Redwood City 40
Seattle 38
Tianjin 35
Nola 34
Falls Church 33
Boardman 25
Kunming 25
Changsha 23
Houston 23
Kronberg 23
San Mateo 23
Lawrence 21
Washington 18
Augusta 16
Pune 16
Dublin 15
Indiana 15
Rome 15
Dearborn 14
Toronto 13
Shanghai 12
Leawood 10
London 10
Milan 10
Ann Arbor 9
Changchun 9
Orange 9
Torre Annunziata 9
Waanrode 9
Ardabil 7
Cava De' Tirreni 7
Delhi 7
Lanzhou 7
Madrid 7
New Delhi 7
New York 7
Bordeaux 6
Halle 6
Hangzhou 6
Hong Kong 6
Paris 6
Tokyo 6
Ankara 5
Beau Bassin-Rose Hill 5
Bristol 5
Davis 5
Guangzhou 5
Monmouth Junction 5
Redmond 5
San Jose 5
Sofia 5
Vienna 5
Acerra 4
Birmingham 4
Buffalo 4
Cape Town 4
Fairfield 4
Frankfurt am Main 4
Fremont 4
Helsinki 4
Saint Louis 4
Salerno 4
Stockholm 4
Telese 4
Xian 4
Atlanta 3
Baden 3
Baltimore 3
Cologne 3
Constanta 3
Dallas 3
Fall River 3
Fuzhou 3
Hefei 3
Hyderabad 3
Messina 3
Mugnano Di Napoli 3
Muizenberg 3
Nocera Inferiore 3
Totale 5.113
Nome #
Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosum. 193
Screening of ARHSP-TCC patients expands the spectrum of SPG11 mutations and includes a large scale gene deletion. 136
Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms. 125
SISTEMA NERVOSO. Neurologia - Neurochirurgia - Neuroradiologia 110
Ataxia-myoclonus syndrome due to a novel homozygous ATP13A2 mutation 66
A novel mutation in SACS gene in a family from southern Italy 61
Epoetin alfa increases frataxin production in Friedreich's ataxia without affecting hematocrit. 61
Modifications of resting state networks in spinocerebellar ataxia type 2 58
A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis. 58
SPG5 and multiple sclerosis: clinical and genetic overlap? 58
PINK1 homozygous W437X mutation in a patient with apparent dominant transmission of parkinsonism. 57
Dimethyl Fumarate Mediates Nrf2-dependent Mitochondrial Biogenesis in Mice and Humans 56
Ataxia with oculomotor apraxia type 1 in southern italy: late onset and variable phenotype. 55
Behavioral disorder, dementia, ataxia and rigidity in a large family with Tata box-Binding Protein mutation 53
Reduced striatal [123I]FP-CIT binding in SCA2 patients without parkinsonism 52
A randomized controlled pilot trial of lithium in spinocerebellar ataxia type 2. 51
Pathological laughter as onset symptom in atypical parkinsonisms 51
Dimethyl fumarate dosing in humans increases frataxin expression: A potential therapy for Friedreich’s Ataxia 50
Recombinant human erythropoietin increasesfrataxin protein expression without increasing mRNA expression 49
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study 49
Application of the p9NORM correction method to timed neuropsychological tests in Parkinson's disease and multiple system atrophy. 49
Ataxia with oculomotor apraxia type 2: a clinical, pathologic, and genetic study 48
Characterization of nigrostriatal dysfunction in spinocerebellar ataxia 17 48
Emotion Recognition and Psychological Comorbidity in Friedreich’s Ataxia 48
Electrophysiologic characterization in spinocerebellar ataxia 17 47
Very late onset in ataxia oculomotor apraxia type I. 47
Relative frequencies of CAG expansions in spinocerebellar ataxia and dentatorubropallidoluysian atrophy in 116 Italian families 46
PPAR-gamma Agonist Azelaoyl PAF Increases Frataxin Protein and mRNA Expression. New Implications for the Friedreich's Ataxia Therapy 46
Cognitive and functional connectivity alterations in Friedreich's ataxia 46
Autosomal dominant hereditary spastic paraplegia: DHPLC-based mutation analysis of SPG4 reveals eleven novel mutations. 45
A new locus for autosomal recessive hereditary spastic paraplegia maps to chromosome 16q24.3. 45
Long term follow-up to evaluate the efficacy of miglustat treatment in Italian patients with Niemann-Pick disease type C 45
Genome-wide scan linkage analysis for Parkinson's disease: The European Genetic Study of Parkinson's disease. 44
Accuracy of clinical diagnostic criteria for Friedreich's ataxia. 44
Cerebellar blood flow in spinocerebellar degenerations: a single photon emission tomography study in 28 patients. 44
The Effect of Cerebellar Degeneration on Human Sensori-motor Plasticity 44
Clinical and genetic studies in hereditary spastic paraplegia with thin corpus callosum 43
Complex phenotype in an Italian family with a novel mutation in SPG3A. 43
Why do some Friedreich's ataxia patients retain tendon reflexes? A clinical, neurophysiological and molecular study. 43
Long-term effect of epoetin alfa on clinical and biochemical markers in friedreich ataxia 43
Comment: CAG repeats in idiopathic Parkinson disease-To screen or not to screen 42
Predictors of survival in spinocerebellar ataxia type 2 population from Southern Italy. 42
Longitudinal study of a cohort of MSA-C patients in South Italy: survival and clinical features 42
Apolipoprotein E4 is probably responsible for the chromosome 19 linkage peak for Parkinson's disease. 41
Ataxia with oculomotor apraxia type 1 in Southern Italy: late onset and variable phenotype 41
DNA damage induced by polyglutamine-expanded proteins. 41
Novel mutation of SACS gene in a Spanish family with autosomal recessive spastic ataxia 41
A double-blind cross-over trial of amantadine hydrochloride in Friedreich's ataxia. 41
Normalization of timed neuropsychological tests with the PATA rate and nine-hole pegboard tests 41
Peripheral markers of autophagy in polyglutamine diseases 41
Influence of GAA expansion size and disease duration on Central Nervous System impairment in Friedreich's Ataxia. Contribution to the understanding of the pathophysiology of the disease 40
Benign hereditary chorea: clinical and neuroimaging features in an Italian family. 40
Functional MRI signal fluctuations highlight altered resting brain activity in Huntington’s disease 40
Adult normative values for the PATA Rate Test 40
Cerebellum and cognition in Friedreich ataxia: a voxel-based morphometry and volumetric MRI study 40
Friedreich's disease. A linkage study in southern andcentral Italy. 39
Chronic Pachymeningitis: a case of neurosyphilis with spastic paraparesis. 39
A randomized clinical trial of lithium in multiple system atrophy. 39
Central cholinergic dysfunction in the adult form of Niemann Pick disease type C: a further link with Alzheimer's disease? 39
Variants associated with Gaucher disease in multiple system atrophy 39
Be aware of Wolfram syndrome when examining ataxic patients 39
Autonomic nervous system abnormalities in spinocerebellar ataxia type 2: a cardiovascular neurophysiologic study. 38
A multilayer perceptron neural network-based approach for the identification of responsiveness to interferon therapy in multiple sclerosis patients 38
Genetic screening for LRRK2 gene G2019S mutation in Parkinson's disease patients from Southern Italy. 38
A new locus for autosomal recessive hereditary spastic paraplegia maps to chromosome 16q24.3. 38
Stability of erythropoietin repackaging in polypropylene syringes for clinical use 38
INTERGENERATIONAL INSTABILITY AND MARKED ANTICIPATION IN SCA-17. 37
Responsiveness of different rating instruments in spinocerebellar ataxia patients 37
A randomized controlled clinical trial of growth hormone in amyotrophic lateral sclerosis: clinical, neuroimaging, and hormonal results. 37
Friedreich's Ataxia Presenting as Isolated Spastic Paraparesis 37
A wearable proprioceptive stabilizer for rehabilitation of limb and gait ataxia in hereditary cerebellar ataxias: a pilot open-labeled study 37
Up-regulation of c-Jun N-terminal kinase pathway in Friedreich's ataxia cells. 36
A novel NKX2.1 mutation in a family with hypothyroidism and benign hereditary chorea. 36
Cerebral blood flow in spinocerebellar degenerations: a single photon emission tomography study in 28 patients. 36
Variable phenotype in a P102L Gerstmann-Straussler-Scheinker Italian family 35
A pathogenetic classification of hereditary ataxias: is the time ripe? 35
Evidence of a genetic marker for early onset in Friedreich's ataxia. 35
A new case of Refsum's disease. A clinical, biochemical and ultrastructural study. 35
A novel mutation in GCH-1 gene in a case of dopa-responsive dystonia. 35
Percutaneous stimulation of mechanoreceptors and peripheral neural transmission in normal subjects and patients with hereditary ataxias. 35
A genetic study of Parkinson's disease. 35
Powerhouse failure and oxidative damage in autosomal recessive spastic ataxia of Charlevoix-Saguenay 35
Spinocerebellar ataxia type 2-neuronopathy or neuropathy? 35
Autosomal dominant cerebellar ataxia type I: multimodal electrophysiological study and comparison between SCA1 and SCA2 patients 34
Mitochondrial DNA haplogroups influence the Friedreich's ataxia phenotype. 34
A new locus for autosomal recessive hereditary spastic paraplegia maps to chromosome 16q24.3. . 33
Age of onset, sex, and cardiomyopathy as predictors of disability and survival in Friedreich's disease: a retrospective study on 119 patients. 33
Friedreich's disease. A linkage study in southern and central Italy. 33
Neurosyphilis with complex partial status epilepticus and mesiotemporal MRI abnormalities mimicking herpes simplex encephalitis 33
Autosomal recessive progressive myoclonus epilepsy with ataxia and mental retardation. 33
Aprataxin 33
Clinical and CT-scan study of a case of cerebellar ataxia and progressive hearing loss: Lichtenstein-Knorr disease? 33
Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study 33
Le atassie ereditarie 33
Serum transferrin receptor levels in Friedreich's and other degenerative ataxias. 32
Early onset autosomal dominant dementia with ataxia, extrapyramidal features, and epilepsy. 32
Course and outcome of a voltage-gated potassium channel antibody negative Morvan's syndrome. 32
A combined nucleic acid and protein analysis in Friedreich ataxia: implications for diagnosis, pathogenesis and clinical trial design. 32
A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy 32
‘Minimal symptom expression’ in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab 32
Totale 4.559
Categoria #
all - tutte 36.160
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.160


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201933 0 0 0 0 0 0 0 0 0 6 7 20
2019/20201.058 452 24 63 13 73 22 21 8 7 113 120 142
2020/2021982 32 60 78 71 76 111 86 43 103 58 180 84
2021/20221.934 50 37 30 34 22 68 32 97 241 158 301 864
2022/20232.398 415 202 52 209 271 242 5 164 310 398 102 28
2023/20241.091 51 209 220 99 64 111 21 299 6 11 0 0
Totale 8.865